RA Capital Nexus Fund II, L.P. insider trades: Hemab Therapeutics Holdings (COAG) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where RA Capital Nexus Fund II, L.P. reports to the SEC
and 10 more companies
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | COAG | ↑ Buy | 2,840,429 | $18.39 | $52.2M | Indirect | May 6, 2026 (0d) |
| Jan 5, 2026 | CLYM | ↑ Buy | 7,111 | $3.50 | $25K | Indirect | Jan 7, 2026 (2d) |
| Dec 12, 2025 | CLYM | ↑ Buy | 314,561 | $2.40 | $755K | Indirect | Dec 15, 2025 (3d) |
| Sep 26, 2025 | PEPG | ↑ Buy | 9,375,000 | $3.20 | $30.0M | Indirect | Sep 30, 2025 (4d) |
| May 14, 2025 | HOWL | ↑ Buy | 536,426 | $0.91 | $487K | Indirect | May 14, 2025 (0d) |
| Mar 7, 2025 | JANX | ↑ Buy | 824,041 | $30.75 | $25.3M | Indirect | Mar 7, 2025 (0d) |
| Oct 18, 2024 | JANX | ↑ Buy | 1,200,000 | $44.75 | $53.7M | Indirect | Oct 22, 2024 (4d) |
| Aug 9, 2024 | ANTX | ↓ Sell | 3,525,094 | $1.08 | $3.8M | Indirect | Aug 13, 2024 (4d) |
| Jun 27, 2024 | ELYM | ↑ Buy | 13,008,546 | $3.84 | $50.0M | Indirect | Jul 1, 2024 (4d) |
| Apr 2, 2024 | BOLD | ↑ Buy | 312,500 | $16.00 | $5.0M | Indirect | Apr 4, 2024 (2d) |
| Mar 27, 2024 | SPRY | ↑ Buy | 1,401,299 | $9.48 | $13.3M | Indirect | Mar 27, 2024 (0d) |
| Mar 21, 2024 | LENZ | ↑ Buy | 933,038 | $15.03 | $14.0M | Indirect | Mar 25, 2024 (4d) |
| Mar 21, 2024 | LENZ | ↑ Buy | 64,971 | $15.03 | $977K | Indirect | Mar 25, 2024 (4d) |
| Feb 9, 2024 | PEPG | ↑ Buy | 2,557,593 | $10.64 | $27.2M | Indirect | Feb 13, 2024 (4d) |
| Sep 21, 2023 | SPRY | ↑ Buy | 2,700,000 | $3.03 | $8.2M | Indirect | Sep 25, 2023 (4d) |
| Aug 29, 2023 | SPRY | ↑ Buy | 3,750,000 | $6.20 | $23.3M | Indirect | Aug 31, 2023 (2d) |
| Aug 18, 2023 | ANTX | ↑ Buy | 1,777,778 | $9.00 | $16.0M | Indirect | Aug 22, 2023 (4d) |
| Jul 21, 2023 | ABOS | ↑ Buy | 5,161,290 | $7.75 | $40.0M | Indirect | Jul 25, 2023 (4d) |
| Jul 19, 2023 | JANX | ↑ Buy | 495,008 | $12.46 | $6.2M | Indirect | Jul 21, 2023 (2d) |
| Mar 30, 2023 | DICE | ↑ Buy | 509,145 | $29.07 | $14.8M | Indirect | Mar 30, 2023 (0d) |
| Mar 27, 2023 | DICE | ↑ Buy | 498,556 | $26.99 | $13.5M | Indirect | Mar 27, 2023 (0d) |
| Nov 17, 2022 | ACRV | ↑ Buy | 3,389,500 | $12.50 | $42.4M | Indirect | Nov 21, 2022 (4d) |
| Oct 17, 2022 | DICE | ↑ Buy | 1,640,000 | $36.50 | $59.9M | See Footenotes | Oct 19, 2022 (2d) |
| Aug 4, 2022 | ANTX | ↑ Buy | 1,909 | $7.51 | $14K | Indirect | Aug 5, 2022 (1d) |
| Jul 27, 2022 | ANTX | ↑ Buy | 23,219 | $7.78 | $181K | Indirect | Jul 28, 2022 (1d) |
| Jun 21, 2022 | ANTX | ↑ Buy | 302 | $7.99 | $2K | Indirect | Jun 23, 2022 (2d) |
| Jun 14, 2022 | ANTX | ↑ Buy | 81,424 | $7.95 | $647K | Indirect | Jun 15, 2022 (1d) |
| May 10, 2022 | PEPG | ↑ Buy | 3,229,200 | $12.00 | $38.8M | Indirect | May 12, 2022 (2d) |
| Mar 29, 2022 | ANTX | ↑ Buy | 1,666,666 | $15.00 | $25.0M | Indirect | Mar 31, 2022 (2d) |
| Mar 29, 2022 | ICVX | ↑ Buy | 184,218 | $4.54 | $837K | Indirect | Mar 30, 2022 (1d) |
| Mar 15, 2022 | CTKB | ↑ Buy | 583,870 | $12.31 | $7.2M | Indirect | Mar 16, 2022 (1d) |
| Mar 11, 2022 | CTKB | ↑ Buy | 634,638 | $12.86 | $8.2M | Indirect | Mar 11, 2022 (0d) |
| Mar 8, 2022 | CTKB | ↑ Buy | 647,264 | $12.74 | $8.2M | Indirect | Mar 8, 2022 (0d) |
| Mar 2, 2022 | CTKB | ↑ Buy | 441,865 | $12.95 | $5.7M | Indirect | Mar 2, 2022 (0d) |
| Feb 25, 2022 | CTKB | ↑ Buy | 420,380 | $13.23 | $5.6M | Indirect | Feb 25, 2022 (0d) |
| Feb 22, 2022 | CTKB | ↑ Buy | 547,380 | $14.06 | $7.7M | Indirect | Feb 22, 2022 (0d) |
| Feb 16, 2022 | CTKB | ↑ Buy | 498,629 | $14.89 | $7.4M | Indirect | Feb 16, 2022 (0d) |
| Sep 17, 2021 | DICE | ↑ Buy | 1,400,000 | $17.00 | $23.8M | Indirect | Sep 20, 2021 (3d) |
| Aug 12, 2021 | ELYM | ↑ Buy | 3,200,000 | $12.50 | $40.0M | Indirect | Aug 16, 2021 (4d) |
| Aug 2, 2021 | ICVX | ↑ Buy | 2,666,666 | $15.00 | $40.0M | Indirect | Aug 4, 2021 (2d) |
| Jul 27, 2021 | CTKB | ↑ Buy | 2,950,000 | $17.00 | $50.1M | Indirect | Jul 29, 2021 (2d) |
| Jul 6, 2021 | ABOS | ↑ Buy | 1,875,000 | $16.00 | $30.0M | Indirect | Jul 8, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other COAG insiders
Open-market trades in the last 12 months
About RA Capital Nexus Fund II, L.P.'s insider trades
RA Capital Nexus Fund II, L.P. is a director at Hemab Therapeutics Holdings (COAG). Since Jul 6, 2021, it has reported 41 open-market purchases worth $796.5M and 1 sale worth $3.8M on SEC Form 4. In the last 12 months: 3 buys ($53.0M).
Its filings also include grants and awards (41 filings), conversions (10 filings), other transactions (4 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every COAG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.